RIPE-KG · Version 1.1.0 · Resource
ripekg:publication-details/RIPEA2D330616160C50F0
https://w3id.org/ripe/ripe-kg/publication-details/RIPEA2D330616160C50F0
| Subject | Predicate | Object |
|---|---|---|
ripekg:evaluation/RIPEA2D330616160C50F0 |
prov:used |
ripekg:publication-details/RIPEA2D330616160C50F0Effect of curcumin nanomicelle on the clinical symptoms of patients with rheumatoid arthritis: A randomized, double‐blind, controlled trial |
ripekg:publication-details/RIPEA2D330616160C50F0Effect of curcumin nanomicelle on the clinical symptoms of patients with rheumatoid arthritis: A randomized, double‐blind, controlled trial |
prism:eIssn |
1756-185X |
ripekg:publication-details/RIPEA2D330616160C50F0Effect of curcumin nanomicelle on the clinical symptoms of patients with rheumatoid arthritis: A randomized, double‐blind, controlled trial |
prism:endingPage |
1862 |
ripekg:publication-details/RIPEA2D330616160C50F0Effect of curcumin nanomicelle on the clinical symptoms of patients with rheumatoid arthritis: A randomized, double‐blind, controlled trial |
prism:issn |
1756-1841 |
ripekg:publication-details/RIPEA2D330616160C50F0Effect of curcumin nanomicelle on the clinical symptoms of patients with rheumatoid arthritis: A randomized, double‐blind, controlled trial |
prism:publicationDate |
2019-09-03 |
ripekg:publication-details/RIPEA2D330616160C50F0Effect of curcumin nanomicelle on the clinical symptoms of patients with rheumatoid arthritis: A randomized, double‐blind, controlled trial |
prism:publicationName |
International Journal of Rheumatic Diseases |
ripekg:publication-details/RIPEA2D330616160C50F0Effect of curcumin nanomicelle on the clinical symptoms of patients with rheumatoid arthritis: A randomized, double‐blind, controlled trial |
prism:startingPage |
1857 |
ripekg:publication-details/RIPEA2D330616160C50F0Effect of curcumin nanomicelle on the clinical symptoms of patients with rheumatoid arthritis: A randomized, double‐blind, controlled trial |
dcterms:publisher |
ripekg:publisher/RIPEP932ECA8E36309A4DWiley |
ripekg:publication-details/RIPEA2D330616160C50F0Effect of curcumin nanomicelle on the clinical symptoms of patients with rheumatoid arthritis: A randomized, double‐blind, controlled trial |
dcterms:title |
Effect of curcumin nanomicelle on the clinical symptoms of patients with rheumatoid arthritis: A randomized, double‐blind, controlled trial |
ripekg:publication-details/RIPEA2D330616160C50F0Effect of curcumin nanomicelle on the clinical symptoms of patients with rheumatoid arthritis: A randomized, double‐blind, controlled trial |
rdf:type |
http://purl.org/spar/fabio/BibliographicMetadata |
ripekg:publication-details/RIPEA2D330616160C50F0Effect of curcumin nanomicelle on the clinical symptoms of patients with rheumatoid arthritis: A randomized, double‐blind, controlled trial |
rdf:type |
rdfs:Resource |
ripekg:publication-details/RIPEA2D330616160C50F0Effect of curcumin nanomicelle on the clinical symptoms of patients with rheumatoid arthritis: A randomized, double‐blind, controlled trial |
rdf:type |
owl:Thing |
ripekg:publication-details/RIPEA2D330616160C50F0Effect of curcumin nanomicelle on the clinical symptoms of patients with rheumatoid arthritis: A randomized, double‐blind, controlled trial |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:publication-details/RIPEA2D330616160C50F0Effect of curcumin nanomicelle on the clinical symptoms of patients with rheumatoid arthritis: A randomized, double‐blind, controlled trial |
rdf:type |
ripe:PublicationDetailsPublication details |
ripekg:publication-details/RIPEA2D330616160C50F0Effect of curcumin nanomicelle on the clinical symptoms of patients with rheumatoid arthritis: A randomized, double‐blind, controlled trial |
rdf:type |
tido:Evidence |
ripekg:publication-details/RIPEA2D330616160C50F0Effect of curcumin nanomicelle on the clinical symptoms of patients with rheumatoid arthritis: A randomized, double‐blind, controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA2D330616160C50F0 |
ripekg:publication-details/RIPEA2D330616160C50F0Effect of curcumin nanomicelle on the clinical symptoms of patients with rheumatoid arthritis: A randomized, double‐blind, controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA2D330616160C50F0 |
ripekg:publication-details/RIPEA2D330616160C50F0Effect of curcumin nanomicelle on the clinical symptoms of patients with rheumatoid arthritis: A randomized, double‐blind, controlled trial |
ripe:concerns |
ripekg:work/10.1111%2F1756-185x.13688Effect of curcumin nanomicelle on the clinical symptoms of patients with rheumatoid arthritis: A randomized, double‐blind, controlled trial |
ripekg:publication-details/RIPEA2D330616160C50F0Effect of curcumin nanomicelle on the clinical symptoms of patients with rheumatoid arthritis: A randomized, double‐blind, controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA2D330616160C50F0-human-1-1 |
ripekg:publication-details/RIPEA2D330616160C50F0Effect of curcumin nanomicelle on the clinical symptoms of patients with rheumatoid arthritis: A randomized, double‐blind, controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA2D330616160C50F0-inspectai-1-1 |